Pakistan’s Leading Pharmaceutical company, Highnoon Pharma once again became the only Pakistani pharmaceutical company making it to Forbes Best Under a Billion. Previously, the company made it to the Forbes list back in 2019. Since then, with the advent of COVID19 pandemic and crisis like situation, Highnoon fared even better.
This is reflective of the fact that the company is performing with more commitment to well-being of society and consequently earning the trust of millions of people suffering from health problems in the country. At a time when COVID impacted the economy in every imaginable way, Highnoon played its role in supporting the Medical industry and pushing the Pakistan’s economy.
Chairman Highnoon Pharma said that “Nothing makes me happier than the fact that our company is growing despite all the possibilities. There are many factors that contribute to this success, and I want to express my sincere gratitude to all stakeholders for their tireless work and their 100% commitment. Practitioners, guidance and most of them are all our heroes; most valuable assets”.
Highnoon Pharma has total assets in excess of Rs. 7 billion with annual sales expected at Rs. 12.5 billion in 2021.
Latest posts by News Desk (see all)
- PSX Weekly Review: 22-September-2023 - September 22, 2023
- Fatima Fertilizer to invest PKR 7.6bn in REITs - September 22, 2023
- EuroZone Economic contraction in September - September 22, 2023
